Related references
Note: Only part of the references are listed.Shigella enterotoxin-2 is a type III effector that participates in Shigella-induced interleukin 8 secretion by epithelial cells
Mauricio J. Farfan et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2011)
Shigella type III secretion effectors: how, where, when, for what purposes?
Claude Parsot
CURRENT OPINION IN MICROBIOLOGY (2009)
Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 ΔicsA Δent Δfep ΔstxA:HgR oral vaccine SC599 in healthy human adult volunteers
Christine Sadorge et al.
VACCINE (2008)
Safety and immunogenicity of WRSd1, a live attenuated Shigella dysenteriae type 1 vaccine candidate
Robin McKenzie et al.
VACCINE (2008)
Safety and immunogenicity of CVD 1208S, a live, oral ΔguaBA Δsen Δset Shigella flexneri 2a vaccine grown on animal-free media
Karen L. Kotloff et al.
HUMAN VACCINES (2007)
Clinical trials of Shigella vaccines:: two steps forward and one step back on a long, hard road
Myron M. Levine et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Shigella's ways of manipulating the host intestinal innate and adaptive immune system:: a tool box for survival?
Armelle Phalipon et al.
IMMUNOLOGY AND CELL BIOLOGY (2007)
Live-attenuated Shigella vaccines
Malabi M. Venkatesan et al.
EXPERT REVIEW OF VACCINES (2006)
Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model
Eileen M. Barry et al.
VACCINE (2006)
Recombinant Shiga toxin B-subunit-keyhole limpet hemocyanin conjugate vaccine protects mice from Shigatoxemia
P Marcato et al.
INFECTION AND IMMUNITY (2005)
A pediatric cluster of Shigella dysenteriae serotype 1 diarrhea with hemolytic uremic syndrome in 2 families from France
V Houdouin et al.
CLINICAL INFECTIOUS DISEASES (2004)
Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208
KL Kotloff et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Genetic characterization and immunogenicity of coli surface antigen 4 from enterotoxigenic Escherichia coli when it is expressed in a Shigella live-vector strain
Z Altboum et al.
INFECTION AND IMMUNITY (2003)
Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine
MM Venkatesan et al.
INFECTION AND IMMUNITY (2002)
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
KA Datsenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli
H Koprowski et al.
INFECTION AND IMMUNITY (2000)
Share Paper
